Merck Financial Diagnostics

MRK -- USA Stock  

USD 85.46  0.19  0.22%

The current investor indifference towards the small price fluctuations of Merck Company may encourage investors to take a closer look at the firm as it closed today at a share price of 85.46 on 1 in trading volume. The company directors and management did not add any value to Merck investors in October. However, most investors can still diversify their portfolios with Merck Company to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.2764. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. This diagnostics interface makes it easy to digest most current publicly released information about Merck as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Merck price relationship with some important fundamental indicators such as market cap and management efficiency. Please see also Stocks Correlation.

Merck Note

About 78.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.74. Merck last dividend was issued on 2019-09-13. The entity had 2:1 split on 1999-02-17. It operates in Pharmaceutical, Animal Health, Healthcare Services, and Alliances segments. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 69000 people. To find out more about MERCK CO INC contact Kenneth Frazier at 908-740-4000 or learn more at

Merck Alerts

Merck has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
Over 78.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Disposition of 8400 shares by Mcdonough Mark E of Merck subject to Rule 16b-3

Merck Upcoming and Recent Events

Upcoming Quarterly Earning ReportFebruary 7, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 7, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Merck Earning Estimates

EPSEstimate Date
Quarterly Estimate1.14February 7, 2020
Merck Company normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Merck SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Results of Operations and Financial Condition
Submission of Matters to a Vote of Security Holders
Financial Statements and Exhibits. Cost Associated with Exit or Disposal Activities. Results of Operations and Financial Condition
Unclassified Corporate Event
Financial Statements and Exhibits. Other Events
Unclassified Corporate Event
Unclassified Corporate Event

Merck Thematic Classifications

Robots And Drones IdeaRobots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Giant Impact IdeaGiant Impact
Public companies with mega capitalization
Compulsion IdeaCompulsion
Addiction driven consumer products and services
Drugs IdeaDrugs
Drug manufacturing and delivery

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares209.5 M17.6 B
Blackrock IncCommon Shares186.1 M15.7 B
State Street CorpCommon Shares115.3 M9.8 B
Capital World InvestorsCommon Shares80.5 M6.8 B
Wellington Management Group LlpCommon Shares57.7 M4.9 B
Bank Of America CorpCommon Shares45.4 M3.8 B
Geode Capital Management LlcCommon Shares39.3 M3.3 B

Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 214.76 B.

Stock Holders for Merck

At Risk
DOW 0.00 (1.19) 
Columbia Global Dividend Opport(0.0181) (1.02) 
CI Signature Global Dividend C 0.00  0.00 
BlackRock Tactical Opportunitie(0.14) (0.37) 
John Hancock ESG All Cap Core F(0.01) (1.36) 
Putnam Global Health Care Fund 0.06 (1.51) 
American Beacon The London Comp(0.0123) (0.66) 
Lord Abbett Health Care Fund - Class A(0.0085) (1.68) 
US High Dividend Low Volatility(0.0188) (0.82) 
ClearBridge Appreciation Fund C(0.0126) (1.15) 
Putnam Focused Equity Class R6 0.11 (1.75) 
Gotham Enhanced Index Plus Fund 0.0166 (0.95) 
Kinetics Mutual Funds Inc The 0.011 (1.21) 
Columbia Disciplined Core Fund 0.0008 (1.50) 
John Hancock ESG All Cap Core F 0.0318 (1.34) 
Legg Mason ClearBridge Tactica(0.12) (1.07) 
NQ US Pharma Biotech Lg Md C 0.17 (1.18) 
NQ US Pharma Biotech Lg Md C 0.39 (1.91) 
NASDAQ N America Health Care Lg 0.06 (1.88) 

Technical Drivers

As of 22 of November Merck secures Risk Adjusted Performance of (0.005147) and Mean Deviation of 0.9767. In connection with Fundamental Indicators, Macroaxis technical analysis interface lets you check existing technical drivers of Merck as well as the relationship between them. Strictly speaking you can use this information to find out if the firm will indeed mirror its model of past prices or the prices will eventually revert. We found nineteen technical drivers for Merck which can be compared to its peers in the industry. Please verify Merck Variance, Value At Risk as well as the relationship between Value At Risk and Skewness to decide if Merck Company is priced some-what accurately providing market reflects its recent price of 85.46 per share. Given that Merck has Jensen Alpha of (0.07), we recommend you check Merck last-minute market performance to make sure the company can sustain itself at future point.

Merck Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Mid-point over period is an average of Merck highest and lowest values attained during the given period. View also all equity analysis or get more info about midpoint over period overlap studies indicator.

Merck Insider Trading Activities

Merck Outstanding Bonds

589331AC1 6.3%01/01/20266.3
589331AD9 6.4%03/01/20286.4
589331AE7 5.95%12/01/20285.95
589331AK3 4.75%03/01/20154.75
589331AM9 5.75%11/15/20365.75
589331AN7 5.0%06/30/20195.0
589331AQ0 5.85%06/30/20395.85
589331AS6 3.6%09/15/20423.6
589331AT4 2.4%09/15/20222.4
58933NAL3 5.76%05/03/20375.76
58933YAA3 3.875%01/15/20213.875
58933YAB1 2.25%01/15/20162.25
58933YAC9 1.1%01/31/20181.1
58933YAD7 0.7%05/18/20160.7
58933YAF2 2.8%05/18/20232.8
58933YAG0 1.3%05/18/20181.3
58933YAJ4 4.15%05/18/20434.15
806605AG6 6.5%12/01/20336.5
806605AH4 6.55%09/15/20376.55
58933YAQ8 2.35%02/10/20222.35
58933YAR6 2.75%02/10/20252.75
58933YAS4 1.85%02/10/20201.85
58933YAT2 3.7%02/10/20453.7

Merck Predictive Indicators

Merck Forecast Models


Merck Analyst Recommendations

Target PriceAdvice# of Analysts
Merck Company current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Merck Analyst Advice  

Vital Value Indicators

Merck Basic Pricing Drivers

Quick Ratio0.81
Fifty Two Week Low70.89
Trailing Annual Dividend Rate2.13
Revenue Growth14.90%
Payout Ratio61.45%
Shares Short Prior Month21.47M
Average Daily Volume Last 10 Day6.85M
Average Daily Volume In Three Month8.06M
Earnings Growth1.40%
Shares Percent Shares Out0.78%
Gross Margins71.71%
Earnings Quarterly Growth-2.50%
Short Percent Of Float0.77%
Forward Price Earnings14.97
Float Shares2.54B
Fifty Two Week High87.35
Enterprise Value To Ebitda13.02
Fifty Day Average83.90
Two Hundred Day Average83.13
Trailing Annual Dividend Yield2.51%
Enterprise Value To Revenue5.12
Please see also Stocks Correlation. Please also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.